S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

PMCB PharmaCyte Biotech Inc

2.175

0.015 (0.69%)

Last Updated: 13:35:46

Delayed by 15 minutes

PharmaCyte completes stability study as part of process to get clinical hold lifted

To read the full story on Seeking Alpha, click here.

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more PharmaCyte Biotech Charts.

PharmaCyte Biotech (NASDAQ:PMCB)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more PharmaCyte Biotech Charts.

PharmaCyte Biotech Inc News

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Wednesday 14 February 2024 (3 months ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Tuesday 6 February 2024 (3 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 15 December 2023 (5 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Tuesday 28 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 24 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

Form SC 13D - General statement of acquisition of beneficial ownership
Wednesday 22 November 2023 (5 months ago) • Edgar (US Regulatory)

More PharmaCyte Biotech Inc News Articles

Brookmount Explorations (PK)

Global Developments (PK)

RespireRx Pharmaceuticals (PK)

Bell Buckle (PK)

Voip Pal Com (QB)

Auto Parts 4Less (PK)

Yuenglings Ice Cream (PK)

Moon Equity (PK)

Progressive Care (QB)

Globestar Therapeutics (PK)

Clean Vision (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions